|
|
 |
|
|
|
|
| Your Result on : Balance Sheet |
|
|
|
|
| Pfizer Ltd |
Industry : Pharmaceuticals - Multinational |
|
|
|
|
|
| Book Value (Rs) |
|
| 921.8834569 |
|
|
|
|
|
|
Market Cap
(Rs In Cr.) |
|
| 25,708 |
|
|
|
|
|
|
|
|
|
|
|
|
| Year |
High (Rs) |
Low (Rs) |
Close (Rs) |
P/E High |
P/E Low |
P/E Close |
Mkt Cap.
(Rs In Cr.) |
| May 2025 |
5,670.60 |
4,156.65 |
5,614.20 |
47.84 |
33.99 |
46.89 |
25,683.69 |
| Apr 2025 |
4,344.40 |
3,742.90 |
4,297.85 |
37.13 |
29.95 |
35.90 |
19,661.69 |
| Mar 2025 |
4,200.00 |
3,867.65 |
4,003.95 |
35.95 |
31.35 |
33.44 |
18,317.16 |
| Feb 2025 |
4,600.20 |
3,914.00 |
4,051.80 |
39.95 |
31.58 |
33.84 |
18,536.07 |
| Jan 2025 |
5,541.00 |
4,385.85 |
4,536.05 |
47.67 |
36.31 |
37.89 |
20,751.40 |
| Share Prices Of
2024
|
| Dec 2024 |
5,451.00 |
4,609.00 |
5,275.70 |
46.09 |
38.02 |
44.07 |
24,135.13 |
| Nov 2024 |
5,442.55 |
5,033.20 |
5,314.45 |
46.68 |
40.78 |
44.39 |
24,312.40 |
| Oct 2024 |
6,039.00 |
5,022.05 |
5,102.00 |
52.17 |
41.29 |
42.61 |
23,340.49 |
| Sep 2024 |
6,452.85 |
5,377.65 |
5,716.35 |
55.02 |
44.65 |
47.75 |
26,151.00 |
| Aug 2024 |
6,100.00 |
5,504.70 |
6,062.65 |
51.26 |
45.50 |
50.64 |
27,735.25 |
| Jul 2024 |
5,671.75 |
4,525.80 |
5,653.60 |
47.53 |
37.23 |
47.22 |
25,863.94 |
| Jun 2024 |
5,010.05 |
4,472.05 |
4,529.45 |
42.57 |
35.81 |
37.83 |
20,721.21 |
| May 2024 |
4,687.10 |
4,170.45 |
4,599.75 |
40.17 |
34.11 |
38.42 |
21,042.81 |
| Apr 2024 |
4,477.00 |
4,050.10 |
4,253.30 |
37.63 |
33.30 |
35.53 |
19,457.88 |
| Mar 2024 |
4,940.00 |
4,082.00 |
4,193.45 |
46.27 |
31.60 |
35.03 |
19,184.08 |
| Feb 2024 |
4,838.90 |
4,305.05 |
4,598.70 |
37.39 |
32.58 |
35.01 |
21,038.01 |
| Jan 2024 |
4,420.75 |
4,141.15 |
4,321.75 |
33.80 |
31.28 |
32.90 |
19,771.03 |
| Share Prices Of
2023
|
| Dec 2023 |
4,331.20 |
3,994.05 |
4,268.60 |
33.48 |
30.05 |
32.49 |
19,527.88 |
| Nov 2023 |
4,162.00 |
3,836.15 |
4,085.55 |
31.92 |
28.81 |
31.10 |
18,690.46 |
| Oct 2023 |
4,042.00 |
3,834.40 |
3,939.40 |
31.40 |
28.38 |
29.99 |
18,021.86 |
|
| PREV |
NEXT
|
|
|
|
|
|
|
|
|
|